Purchases and Sales Made in Q4 2022 in Pyxis Oncology, Inc. (PYXS)
This table provides information about the institutional ownership of Pyxis Oncology, Inc. (PYXS) during Q4 2022. The information is specifically focused on institutions that hold shares of Pyxis Oncology, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
Tang Capital Management LLC
San Diego, CA |
BUY
|
- |
2.09M+ 151.67% |
$2.38M - $4.18M
|
3.47M
$6.56M
|
|
Feb 14, 2023
Q4 2022
|
Newtyn Management, LLC
New York, NY |
BUY
|
- |
700K+ 87.5% |
$798K - $1.4M
|
1.5M
$2.84M
|
|
Jan 12, 2023
Q4 2022
|
Marquette Asset Management, LLC
|
BUY
|
- |
58.9KNew |
$67.1K - $118K
|
58.9K
$111K
|
|
Feb 14, 2023
Q4 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
50K+ 41.56% |
$57K - $100K
|
170K
$322K
|
|
Mar 14, 2024
Q4 2022
|
University Of Chicago
Chicago, IL |
BUY
|
- |
48.7KNew |
$55.6K - $97.5K
|
48.7K
$92.1K
|
|
Feb 14, 2023
Q4 2022
|
Acadian Asset Management LLC
Boston, MA |
BUY
|
- |
47.9K+ 200.73% |
$54.6K - $95.7K
|
71.7K
$136K
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
BUY
|
- |
45.2K+ 14.48% |
$51.6K - $90.5K
|
358K
$676K
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
43.5K+ 216.63% |
$49.6K - $87K
|
63.6K
$120K
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
32K+ 2.09% |
$36.5K - $64K
|
1.56M
$2.95M
|
|
Feb 14, 2023
Q4 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
31.3K+ 101.0% |
$35.7K - $62.6K
|
62.3K
$118K
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
15.1K+ 8.0% |
$17.2K - $30.2K
|
204K
$385K
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
4.78K+ 2.31% |
$5.45K - $9.56K
|
211K
$399K
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
443+ 0.05% |
$505 - $886
|
918K
$1.73M
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
400+ 0.04% |
$456 - $800
|
948K
$1.79M
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
14+ 9.59% |
$16 - $28
|
160
$302
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 14, 2023
Q4 2022
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-1- -0.0% |
$1.14 - $2
|
669K
$1.26M
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-2.2K- 5.84% |
$2.51K - $4.4K
|
35.5K
$67.1K
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-9.56K- 60.74% |
$10.9K - $19.1K
|
6.18K
$11.7K
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-15.6K- 12.77% |
$17.8K - $31.2K
|
106K
$201K
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-45.2K- 35.09% |
$51.5K - $90.4K
|
83.6K
$158K
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-58.5K- 65.12% |
$66.7K - $117K
|
31.3K
$59.2K
|